Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2

被引:63
作者
Suhre, WM
Ekins, S
Chang, C
Swaan, PW
Wright, SH [1 ]
机构
[1] Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA
[2] Concurrent Pharmaceut, Ft Washington, PA USA
[3] Univ Maryland Baltimore Cty, Dept Pharmaceut Sci, Baltimore, MD 21228 USA
关键词
D O I
10.1124/mol.104.004713
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Organic cation transporters are important for the elimination of many drugs and toxins from the body. In the present study, substrate-transporter interactions were investigated in Chinese hamster ovary cells stably transfected with either the human or rabbit orthologs of the principal organic cation transporter in the kidney, OCT2. IC50 values, ranging from 0.04 mu M to > 3 mM, for inhibition of [C-14]tetraethylammonium transport were determined for more than 30 structurally diverse compounds. Although the two OCT orthologs displayed similar IC50 values for some of these compounds, the majority varied by as much as 20-fold. Marked differences in substrate affinity were also noted when comparing hOCT2 to the closely related homolog hOCT1. These data suggest the molecular determinants of substrate binding differ markedly among both homologous and orthologous OCT transporters. The software package Cerius(2) (Accelrys, San Diego, CA) was used to generate a descriptor-based, two-dimensional, quantitative structure-activity relationship (QSAR) to produce a model relating the affinity of hOCT2 to particular physicochemical features of substrate/ inhibitor molecules (r(2) = 0.81). Comparative molecular field analysis (Tripos, St. Louis, MO) was used to generate three-dimensional QSARs describing the structural basis of substrate binding to hOCT2 and rbOCT2 (q(2) = 0.60 and 0.53, respectively, and each with r(2) = 0.97). The quality of the models was assessed by their ability to successfully predict the inhibition of a set of test compounds. The current models enabled prediction of OCT2 affinity and may prove useful in the prediction of unwanted drug interactions at the level of the renal secretory process.
引用
收藏
页码:1067 / 1077
页数:11
相关论文
共 35 条
[1]   Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1 [J].
Arndt, P ;
Volk, C ;
Gorboulev, V ;
Budiman, T ;
Popp, C ;
Ulzheimer-Teuber, I ;
Akhoundova, A ;
Koppatz, S ;
Bamberg, E ;
Nagel, G ;
Koepsell, H .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (03) :F454-F468
[2]   PHYSIOLOGICAL PHARMACOKINETIC MODELING [J].
BALANT, LP ;
GEXFABRY, M .
XENOBIOTICA, 1990, 20 (11) :1241-1257
[3]   The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [J].
Barendt, WM ;
Wright, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22491-22496
[4]   Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1 [J].
Bednarczyk, D ;
Ekins, S ;
Wikel, JH ;
Wright, SH .
MOLECULAR PHARMACOLOGY, 2003, 63 (03) :489-498
[5]   NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules [J].
Bednarczyk, D ;
Mash, EA ;
Aavula, BR ;
Wright, SH .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 440 (01) :184-192
[6]   Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine [J].
Busch, AE ;
Karbach, U ;
Miska, D ;
Gorboulev, V ;
Akhoundova, A ;
Volk, C ;
Arndt, P ;
Ulzheimer, JC ;
Sonders, MS ;
Baumann, C ;
Waldegger, S ;
Lang, F ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :342-352
[7]   Prediction of pharmacokinetic properties using experimental approaches during early drug discovery [J].
Chaturvedi, PR ;
Decker, CJ ;
Odinecs, A .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) :452-463
[8]  
Clement OO, 2000, IUL BIOTECH, V2, P69
[9]   Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2) [J].
Dresser, MJ ;
Xiao, GQ ;
Leabman, MK ;
Gray, AT ;
Giacomini, KM .
PHARMACEUTICAL RESEARCH, 2002, 19 (08) :1244-1247
[10]   Predicting undesirable drug interactions with promiscuous proteins in silico [J].
Ekins, S .
DRUG DISCOVERY TODAY, 2004, 9 (06) :276-285